WO2002074941A8 - Reportervirus mit heterologen hüllproteinen - Google Patents
Reportervirus mit heterologen hüllproteinenInfo
- Publication number
- WO2002074941A8 WO2002074941A8 PCT/EP2002/003185 EP0203185W WO02074941A8 WO 2002074941 A8 WO2002074941 A8 WO 2002074941A8 EP 0203185 W EP0203185 W EP 0203185W WO 02074941 A8 WO02074941 A8 WO 02074941A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- envelope proteins
- reporter virus
- virus
- reporter
- heterologous envelope
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15041—Use of virus, viral particle or viral elements as a vector
- C12N2740/15045—Special targeting system for viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15061—Methods of inactivation or attenuation
- C12N2740/15062—Methods of inactivation or attenuation by genetic engineering
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16045—Special targeting system for viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16061—Methods of inactivation or attenuation
- C12N2740/16062—Methods of inactivation or attenuation by genetic engineering
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002310969A AU2002310969A1 (en) | 2001-03-21 | 2002-03-21 | Reporter virus comprising heterologous envelope proteins |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10113864.4 | 2001-03-21 | ||
DE10113864 | 2001-03-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002074941A1 WO2002074941A1 (de) | 2002-09-26 |
WO2002074941A8 true WO2002074941A8 (de) | 2002-10-24 |
Family
ID=7678450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/003185 WO2002074941A1 (de) | 2001-03-21 | 2002-03-21 | Reportervirus mit heterologen hüllproteinen |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002310969A1 (de) |
WO (1) | WO2002074941A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060222661A1 (en) | 2002-09-13 | 2006-10-05 | Birke Bartosch | Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
EP1398371A1 (de) * | 2002-09-13 | 2004-03-17 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Infektiöse HCV Pseudopartikel mit funktionellen E1 and E2 Hüllproteinen |
EP1454989A1 (de) * | 2003-03-03 | 2004-09-08 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Infektiöse HCV Pseudo-Partikel, welche native funktionelle E1 und E2 Proteine beinhalten |
EP1454988A1 (de) * | 2003-03-03 | 2004-09-08 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Infektiöse Flavivirus Pseudo-Partikel, welche funktionelle prM-E Hüllproteine enthalten |
EP1687325A4 (de) | 2003-11-12 | 2008-11-12 | Progenics Pharm Inc | Neue, für glykoproteine des hepatitis c virus kodierende sequenzen |
JPWO2007029857A1 (ja) * | 2005-09-09 | 2009-03-19 | 国立大学法人群馬大学 | B型肝炎ウイルスの感染性の測定方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4096100A (en) * | 1999-04-23 | 2000-11-10 | Centre For Translational Research In Cancer | Pseudotyped retroviral vector for gene therapy of cancer |
-
2002
- 2002-03-21 WO PCT/EP2002/003185 patent/WO2002074941A1/de not_active Application Discontinuation
- 2002-03-21 AU AU2002310969A patent/AU2002310969A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2002310969A1 (en) | 2002-10-03 |
WO2002074941A1 (de) | 2002-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003054197A3 (de) | A librairy of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism | |
WO2002099035A3 (en) | Chimeric alphavirus replicon particles | |
WO2004112831A3 (en) | High titer recombinant influenza viruses for vaccines and gene therapy | |
HK1152081A1 (en) | Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class i membrane fusogenic envelope proteins | |
EP1394259A3 (de) | Rekombinantes infektiöses nicht-in-Segmente-geteiltes negativ-Strange-RNS-Virus | |
PT1294892E (pt) | Montagem de partículas semelhantes a vírus (vlps) de influenza de tipo selvagem e quiméricas | |
IL163646A0 (en) | Recombinant parainfluenza virus expression systemsand vaccines comprising heterologous antigens derived from metapneumovirus | |
WO2003068923A3 (en) | Signal for packaging of influenza virus vectors | |
WO2003023040A3 (en) | Vaccinia virus mva-e3l-knockout-mutants and use thereof | |
WO2022063986A3 (en) | Synthetic viruses | |
WO2002074941A8 (de) | Reportervirus mit heterologen hüllproteinen | |
WO2004048402A3 (en) | A hepatitis c virus codon optimized non-structural ns3/4a fusion gene | |
WO2004048582A3 (en) | Recombinant poxvirus comprising at least two cowpox ati promoters | |
WO2005035712A3 (en) | Methods and compositions for infectious cdna of sars coronavirus | |
WO2003072725A3 (en) | Recombinant negative strand virus rna expression systems and vaccines | |
MXPA02012593A (es) | Particulas de tipo virus del virus de la diarrea viral bovina. | |
WO2003053332A3 (en) | Composition and method for treating viral infection | |
WO2002042450A8 (en) | Sugarcane bacilliform virus promoters derived from isolates isolated from sugarcane cultivars | |
WO2003016521A3 (de) | Aav-vektor-verpackungsplasmide zur helfervirus-freien herstellung von wtaav-partikeln oder pseudotypisierten aav-partikeln über einzeltransfektion | |
WO2004104032A3 (en) | Methods and compositions related to high-titer pseudotyped retroviruses | |
WO2004048403A3 (en) | Hepatisis c virus nonstructural protein 4a (ns4a) is an enhancer element | |
ATE489106T1 (de) | Virusähnliche partikel, verfahren zur herstellung und immunogene zusammensetzungen | |
WO2003057824A3 (en) | Compositions and methods for the inhibition of membrane fusion by paramyxoviruses | |
WO2003072771A3 (en) | Method of preparing a treatment product using a togaviridae expression construct | |
WO2004007747A3 (en) | Assays for assembly of ebola virus nucleocapsids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: PAT. BUL. 39/2002 UNDER (51) REPLACE THE EXISTING SYMBOLS BY "C12N 7/01, C12Q 1/70" Free format text: PAT. BUL. 39/2002 UNDER (51) REPLACE THE EXISTING SYMBOLS BY "C12N 7/01, C12Q 1/70" |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |